Triple Helix Discovery Engine
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
BioSpace: BioCapital
*Industry: Maryland
*Industry: Montgomery County
*Industry: Rockville, Maryland
Nuo Therapeutics, formerly, Cytomedix, Inc. (OTCBB: CMXI)

Organization & Developments: Cytomedix

Parents

416 Hungerford Dr Ste 330
Cytomedix bought the Angel Whole Blood Separation System and activAT Autologous Thrombin Processing Kit products from Italy-base
Cytomedix makes and sells its AutoloGel System, a device cleared by the FDA that produces platelet-rich plasma from a patient’s
Cytomedix, Inc. is a biotechnology company specializing in processes and products derived from autologous platelet releasates
For use on wounds and other applications.
In 2009, AutoloGel earned Cytomedix $226,000 in product sales
In all, the company generated $2.1 million in revenue in 2009
Roughly $1.8 million of 2009 revenue stemmed from royalties associated with nine licensing agreements Cytomedix had signed with
The activAT kit yielded $200,000 in revenue 2009 through its production of autologous thrombin serum from platelet-poor plasma.
The Angel system, which earned Sorin $4.8 million in revenue 2009, processes and separates blood into red cells, platelet poor p
The current offering is the AutoloGel(tm) System, a process that utilizes an autologous platelet gel composed of multiple growth